Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum proteomic profiling of major depressive disorder
Mariska Bot, Man K. Chan, Rick Jansen, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 7, pp. e599-e599
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Yuri Milaneschi, Femke Lamers, Michael Berk, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 5, pp. 369-380
Closed Access | Times Cited: 311
Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders
Yi Liu, Jingping Zhao, Wenbin Guo
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 197
Data-driven biological subtypes of depression: systematic review of biological approaches to depression subtyping
Lian Beijers, Klaas J. Wardenaar, Hanna M. van Loo, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 6, pp. 888-900
Open Access | Times Cited: 193
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Bharathi S. Gadad, Manish K. Jha, Andrew H. Czysz, et al.
Journal of Affective Disorders (2017) Vol. 233, pp. 3-14
Open Access | Times Cited: 173
Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?
J. Herbert, Paul J. Lucassen
Frontiers in Neuroendocrinology (2015) Vol. 41, pp. 153-171
Open Access | Times Cited: 136
Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
Ashley L. Comes, Sergi Papiol, Thorsten Müeller, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 86
Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
Shusheng Wu, Yuye Yin, Longfei Du
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 8, pp. 2571-2591
Closed Access | Times Cited: 73
Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders
Brenda W.J.H. Penninx, Merijn Eikelenboom, Erik J. Giltay, et al.
Journal of Affective Disorders (2021) Vol. 287, pp. 69-77
Open Access | Times Cited: 63
The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System
Jan Korbecki, Magdalena Gąssowska-Dobrowolska, Jerzy Wójcik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4205-4205
Open Access | Times Cited: 51
Gut-derived lactic acid enhances tryptophan to 5-hydroxytryptamine in regulation of anxiety via Akkermansia muciniphila
Miaomiao Pan, Chenhao Qian, Shaoye Huo, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
GWAS-based machine learning approach to predict duloxetine response in major depressive disorder
Małgorzata Maciukiewicz, Victoria S. Marshe, Anne-Christin Hauschild, et al.
Journal of Psychiatric Research (2018) Vol. 99, pp. 62-68
Closed Access | Times Cited: 77
Serum proteomic profiles of depressive subtypes
Femke Lamers, Mariska Bot, Rick Jansen, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 7, pp. e851-e851
Open Access | Times Cited: 70
Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model
Irene López-Vílchez, Maribel Díaz‐Ricart, Víctor M. Navarro, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 9, pp. e886-e886
Open Access | Times Cited: 70
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Gerwyn Morris, Basant K. Puri, Lisa Olive, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)
Jordan M. Ramsey, Jason D. Cooper, Mariska Bot, et al.
PLoS ONE (2016) Vol. 11, Iss. 5, pp. e0156624-e0156624
Open Access | Times Cited: 67
Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies
Ana Paula Mendes‐Silva, Kelly Silva Pereira, Gesiane Thamire Tolentino-Araújo, et al.
American Journal of Geriatric Psychiatry (2016) Vol. 24, Iss. 10, pp. 903-912
Closed Access | Times Cited: 62
Genome-wide association study meta-analysis of dizygotic twinning illuminates genetic regulation of female fecundity
Hamdi Mbarek, Scott D. Gordon, David L. Duffy, et al.
Human Reproduction (2023) Vol. 39, Iss. 1, pp. 240-257
Open Access | Times Cited: 18
Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype
Breno S. Diniz, Charles F. Reynolds, Etienne Sibille, et al.
American Journal of Geriatric Psychiatry (2016) Vol. 25, Iss. 1, pp. 64-72
Open Access | Times Cited: 59
Plasma metabolome analysis of patients with major depressive disorder
Noriyuki Kawamura, Kosaku Shinoda, Hajime Satō, et al.
Psychiatry and Clinical Neurosciences (2018) Vol. 72, Iss. 5, pp. 349-361
Open Access | Times Cited: 53
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 26
Circulating biosignatures of late-life depression (LLD): Towards a comprehensive, data-driven approach to understanding LLD pathophysiology
Breno S. Diniz, Chien‐Wei Lin, Etienne Sibille, et al.
Journal of Psychiatric Research (2016) Vol. 82, pp. 1-7
Open Access | Times Cited: 46
Proteomic characterization of hippocampus of chronically socially isolated rats treated with fluoxetine: Depression-like behaviour and fluoxetine mechanism of action
Ivana Perić, Victor Costina, Andrijana Stanisavljević, et al.
Neuropharmacology (2018) Vol. 135, pp. 268-283
Closed Access | Times Cited: 46
Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users
Mariska Bot, Yuri Milaneschi, Brenda W.J.H. Penninx, et al.
Psychoneuroendocrinology (2016) Vol. 68, pp. 148-155
Closed Access | Times Cited: 44
Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults
Breno S. Diniz, Charles F. Reynolds, Etienne Sibille, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Jordan M. Ramsey, Jason D. Cooper, Brenda W.J.H. Penninx, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top